EUVIMEDEUVIMED entdecken
Crossref

Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection

Mona A Omar, Rabab El Hawary, Alia Eldash, Khaled M Sadek, Neveen A Soliman, Mariam Onsy F Hanna iD, Shereen M Shawky

Laboratory Medicine · 07.03.2024 · 55 (2) · 153-161

DOI: 10.1093/labmed/lmad050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 23.06.2023. Verfasst von Mona A Omar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While we strive to live with SARS-CoV-2, defining the immune response that leads to recovery rather than severe disease remains highly important. COVID-19 has been associated with inflammation and a profoundly suppressed immune response.

Objective

To study myeloid-derived suppressor cells (MDSCs), which are potent immunosuppressive cells, in SARS-CoV-2 infection.

Results

Patients with severe and critical COVID-19 showed higher frequencies of neutrophilic (PMN)–MDSCs than patients with moderate illness and control individuals (P = .005). Severe disease in individuals older and younger than 60 years was associated with distinct PMN-MDSC frequencies, being predominantly higher in patients of 60 years of age and younger (P = .004). However, both age groups showed comparable inflammatory markers. In our analysis for the prediction of poor outcome during hospitalization, MDSCs were not associated with increased risk of death. Still, patients older than 60 years of age (odds ratio [OR] = 5.625; P = .02) with preexisting medical conditions (OR = 2.818; P = .003) showed more severe disease and worse outcome. Among the immunological parameters, increased C-reactive protein (OR = 1.015; P = .04) and lymphopenia (OR = 5.958; P = .04) strongly identified patients with poor prognosis.

Conclusion

PMN-MDSCs are associated with disease severity in COVID-19; however, MDSC levels do not predict increased risk of death during hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsCOVID-19HumansSARS-CoV-2Inflammation

Stichwörter der Autor:innen

COVID-19MDSCSARS-CoV-2agingmortalityseverity

Autor:innen und Institutionen

  • Department of Clinical Pathology, Cairo University, Cairo, Egypt.
  • Department of Internal Medicine and Nephrology, Cairo University, Cairo, Egypt.
  • Department of Pediatrics, Cairo University, Cairo, Egypt.

ORCID-Profile: Mariam Onsy F Hanna

Zitieren

APA

Omar, M. A., El Hawary, R., Eldash, A., Sadek, K. M., Soliman, N. A., Hanna, M. O. F., & Shawky, S. M. (2024). Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection. Laboratory Medicine, 55(2), 153-161. https://doi.org/10.1093/labmed/lmad050

Vancouver

Omar MA, El Hawary R, Eldash A, Sadek KM, Soliman NA, Hanna MOF, et al. Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection. Laboratory Medicine. 2024;55(2):153-161. doi:10.1093/labmed/lmad050

BibTeX
@article{Omar2024,
  author = {Omar, Mona A and El Hawary, Rabab and Eldash, Alia and Sadek, Khaled M and Soliman, Neveen A and Hanna, Mariam Onsy F and Shawky, Shereen M},
  title = {Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection},
  journal = {Laboratory Medicine},
  year = {2024},
  volume = {55},
  number = {2},
  pages = {153--161},
  doi = {10.1093/labmed/lmad050}
}
Kostenlos starten →